Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 inhibitors, GLP-1 receptor agonists, and more.

Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications.

Incorporating metformin in burn metabolic care may help control hyperglycemia and broader metabolic dysfunction linked to ...

USA: A retrospective comparative effectiveness study among veterans with type 2 diabetes found that three GLP-1 receptor agonists — semaglutide, liraglutide, and dulaglutide—showed similar risks for ...